Senti Biosciences, INC. (SNTI) SEC Filings — 2025
17 SEC filings for Senti Biosciences, INC. (SNTI) in 2025.
Filings
- Senti Biosciences, INC. 8-K Filing — 8-K · Dec 9, 2025
- Senti Biosciences' Cash Dwindles Amid Rising R&D, Going Concern Looms — 10-Q · Nov 13, 2025
- Senti Biosciences Remains Pre-Revenue, Focuses on GeneFab Development — 10-Q · Aug 7, 2025
- Senti Biosciences Files 8-K on Executive Changes — 8-K · Jul 18, 2025
- Senti Biosciences Reports on Shareholder Votes — 8-K · Jun 30, 2025
- Senti Biosciences Files 8-K — 8-K · Jun 18, 2025
- Senti Biosciences Files Q1 2025 10-Q — 10-Q · May 6, 2025
- Senti Biosciences Files Proxy Statement for June Meeting — DEF 14A · Apr 30, 2025
- Senti Biosciences Files 8-K on Financials and Operations — 8-K · Apr 28, 2025
- Senti Biosciences Enters Material Definitive Agreement — 8-K · Mar 24, 2025
- Senti Biosciences Files 2024 10-K — 10-K · Mar 20, 2025
- Senti Biosciences Board Changes and Officer Compensation — 8-K · Mar 10, 2025
- Senti Biosciences Files 8-K on Shareholder Votes & Financials — 8-K · Mar 7, 2025
- Senti Biosciences Files 8-K: Director Departs, Disclosures Made — 8-K · Feb 25, 2025
- Senti Biosciences Reports Executive and Director Changes — 8-K · Feb 6, 2025
- Senti Biosciences Files Definitive Proxy Statement — DEF 14A · Jan 27, 2025
- Senti Biosciences Files 8-K on Financial Obligations & Equity Sales — 8-K · Jan 6, 2025